 |
|
|
|
 |
|
|
| Article 1 to 10 out of 56 concerning Agilent Technologies Inc.
|
-
Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays
(05/19/2008)
Agilent Technologies Inc. and Signature Genomic Laboratories LLC announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays to Signature and its customers based on the Signature-designed ...
-
Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity
(05/09/2008)
Dow Nucleic Acids Medicines Business Assets Acquired
Agilent Technologies Inc. announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, ...
-
Agilent Technologies Secures Exclusive License to Aktiv-Dry CAN-BD Spray-Drying Technology for Nucleic Acid API's
(05/06/2008)
Agilent Technologies Inc. announced that it has secured an exclusive license to Aktiv-Dry's CAN-BD drying technology for nucleic acid active pharmaceutical ingredients (API's). Can-BD is a continuous drying technology that produces uniform particles ...
-
Oxford Gene Technology appointed Agilent Certified Service Provider (CSP) in Europe
(03/12/2008)
Oxford Gene Technology (OGT) and Agilent Technologies, Inc. announced OGT's officially granted status as an Agilent microarray Certified Service Provider (CSP) in Europe following the completion of several successful projects. To date, OGT has been ...
-
Invitrogen, Agilent Technologies Settle Multiple Patent Litigations
(02/08/2008)
Settlement resolves all pending patent litigations between two companies
Invitrogen Corporation (IVGN) and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen ...
-
Agilent Technologies and BioNanomatrix to Develop Genetic Analysis System Using Nanoscale Whole Genome Imaging Technology
(11/09/2007)
Agilent Technologies Inc. and BioNanomatrix Inc. announced that they have entered into a collaboration to develop a new genetic analysis system combining the two companies' technologies. BioNanomatrix, which develops breakthrough nanoscale whole ...
-
Complex Mixtures of Targeting Oligonucleotides Unlock the Power of Next-Generation DNA Sequencers
(10/22/2007)
A group of researchers at Harvard Medical School, Virginia Commonwealth University, Agilent Technologies Inc., Codon Devices Inc., and Stanford University has used complex mixtures of oligonucleotides in the form of oligonucleotide library synthesis ...
-
Agilent Technologies Tools Used to Derive New Type of Mouse Embryonic Stem Cell that Shares Key Features of Human Embryonic Stem
(07/30/2007)
Using a variety of Agilent Technologies genomics tools, researchers at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and the University of Oxford, U.K., have achieved a major milestone in ...
-
Agilent Technologies Expands Genomics Network in Asia Pacific
(07/26/2007)
Agilent Technologies Inc. announced that it has signed five distributors to sell and distribute genomics products for microarray analysis. The distributors service India, Indonesia, Korea, Hong Kong, China and Australia. In addition, Agilent has ...
-
Agilent Technologies Licenses Labeling Technology from Kreatech Technology
(07/12/2007)
First CGH Microarrays Optimized for FFPE Samples
Agilent Technologies Inc. and Kreatech Biotechnology B.V. announced that Agilent has licensed novel labeling technology from Kreatech, which will optimize Agilent's array-based comparative genomic hybridization (aCGH) platform for DNA from ...
|
|
|
|
|
Top